Top Markets
Coin of the day
Boule Diagnostics AB Boule Diagnostics AB

Boule Diagnostics AB

BOUL
Rank in Stocks #31118
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and... Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, and Medonic brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories, and veterinary clinics, and other diagnostics firms. The company was founded in 1956 and is headquartered in Spånga, Sweden.
Share Price
$0.36858866
Market Cap
$14.31M
Change (1 day)
-2.94%
Change (1 year)
-45.29%
Country
SE
Trade Boule Diagnostics AB (BOUL)

Category

P/B ratio for Boule Diagnostics AB (BOUL)
P/B ratio as of 2026 TTM: 0
According to Boule Diagnostics AB latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Boule Diagnostics AB from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors